ストックスクリーナーアプリを入手
22.24
4.30%
-1.00
アフターアワーズ：
22.24
前日終値:
$23.24
開ける：
$22.51
24時間の取引高:
303.10K
Relative Volume:
0.87
時価総額：
$1.30B
収益：
$83.72M
当期純損益:
$-143.89M
株価収益率:
-7.9067
EPS:
-2.8128
ネットキャッシュフロー:
$-120.48M
1週間 パフォーマンス:
-8.02%
1か月 パフォーマンス:
+11.59%
6か月 パフォーマンス:
-5.76%
1年 パフォーマンス:
+33.73%
1日の値動き範囲:
$22.06
$23.13
1週間の範囲:
$21.03
$26.52
52週間の値動き範囲:
$14.10
$30.00
Kestra Medical Technologies Ltd Stock (KMTS) Company Profile
名前
Kestra Medical Technologies Ltd
セクター
電話
(425) 279-8002
住所
3933 LAKE WASHINGTON BLVD NE, KIRKLAND
Compare KMTS vs ISRG, BDX, MDLN, ALC, RMD
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
KMTS
Kestra Medical Technologies Ltd
|
22.24 | 1.36B | 83.72M | -143.89M | -120.48M | -2.8128 |
ISRG
Intuitive Surgical Inc
|
350.06 | 125.08B | 11.03B | 3.16B | 2.83B | 8.7254 |
BDX
Becton Dickinson Co
|
153.84 | 42.57B | 21.37B | 1.41B | 3.07B | 3.9437 |
MDLN
Medline Inc
|
39.09 | 32.88B | 29.14B | 1.07B | 1.05B | 1.1956 |
ALC
Alcon Inc
|
67.35 | 34.16B | 10.63B | 819.00M | 1.59B | 1.6577 |
RMD
Resmed Inc
|
195.80 | 28.81B | 5.54B | 1.52B | 1.74B | 10.37 |
Kestra Medical Technologies Ltd Stock (KMTS) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-11-18 | 開始されました | BTIG Research | Buy |
| 2025-03-31 | 開始されました | BofA Securities | Buy |
| 2025-03-31 | 開始されました | Goldman | Neutral |
| 2025-03-31 | 開始されました | Piper Sandler | Overweight |
| 2025-03-31 | 開始されました | Stifel | Buy |
| 2025-03-31 | 開始されました | Wells Fargo | Overweight |
| 2025-03-31 | 開始されました | Wolfe Research | Outperform |
すべてを表示
Kestra Medical Technologies Ltd (KMTS) 最新ニュース
Kestra Medical Technologies (NASDAQ:KMTS) Coverage Initiated at Oppenheimer - MarketBeat
Oppenheimer Initiates Kestra Medical at Market Perform - Moomoo
Goodwin Guides IP For Pharmakon On Up To $200 Million Financing For Kestra Medical Technologies - Mondaq
Kestra Medical Technologies, Ltd. (NASDAQ:KMTS) Receives Consensus Recommendation of "Hold" from Brokerages - MarketBeat
Kestra Medical Technologies, Ltd. (KMTS) reports Q4 loss, tops revenue estimates - MSN
Kestra Medical Technologies Insider Sold Shares Worth $336,609, According to a Recent SEC Filing - Moomoo
Form 4 Kestra Medical Technologies Inc For: 17 July By Investing.com - Investing.com Nigeria
Wall Street Zen Downgrades Kestra Medical Technologies (NASDAQ:KMTS) to Sell - MarketBeat
Kestra Medical Technologies CEO Webster sells $336,609 in stock - Investing.com UK
Kestra Medical CEO Brian Daniel Webster sells USD 333,745 of common shares - Bitget
Form 4 Kestra Medical Technologies Inc For: 17 July - Investing.com India
Kestra Medical Technologies (KMTS) awards 39,113 shares to its CBO - Stock Titan
Kestra Medical Technologies (KMTS) CCO awarded 58,832 performance-based shares - Stock Titan
Kestra Medical Technologies CEO Webster sells $336,609 in stock By Investing.com - Investing.com UK
Kestra Medical (KMTS) CFO receives 44,118 performance-based shares - Stock Titan
Kestra Medical (KMTS) counsel earns 58,832-share stock award - Stock Titan
Kestra Medical Technologies, Ltd. Common Stock (NASDAQ: KMTS) Stock Price, News & Analysis - Kalkine
A Quick Look at Today's Ratings for Kestra Medical Technologies(KMTS.US), With a Forecast Between $30 to $32 - Moomoo
Analysts Offer Insights on NA Companies: Janus Living, Inc. Class A (JAN) and Kestra Medical Technologies Ltd. (KMTS) - The Globe and Mail
Kestra Medical Technologies Earnings Call Highlights Rapid Growth - TipRanks
Kestra Medical Technologies (KMTS) Could Be 31% Overvalued As Earnings And 2027 Guidance Land - simplywall.st
Akin, an Elite Global Law Firm - akingump.com
Kestra Medical Technologies Inc Outlook FY Re - Moomoo
Kestra Medical (NASDAQ: KMTS) investor Brian Webster plans 15,000-share sale - Stock Titan
Kestra Medical Technologies, Ltd. Stock 12‑Month Price Target Raised to $28.43, Implies 18% Upside - TradingView
Kestra Medical Technologies (NASDAQ:KMTS) Stock Price Down 8.7% After Earnings Miss - MarketBeat
Kestra Medical Technologies (NASDAQ:KMTS) Stock Price Expected to Rise, BTIG Research Analyst Says - MarketBeat
Kestra Medical Technologies secures USD 200M of non-dilutive financing - Medical Buyer
Kestra Medical Technologies, Ltd. Stock 12‑Month Price Target Cut to $27.5, Implies 14% Upside - TradingView
Kestra Medical Technologies Reports Strong Fiscal 2026 Growth - TipRanks
KMTS SWOT Analysis: Key Insights from 10-K Filing - GuruFocus
Earnings call transcript: Kestra Medical posts strong Q4 2026 sales, misses EPS - Investing.com Canada
Kestra Medical secures $75M loan facility with Pharmakon - Investing.com UK
Kestra Medical (KMTS) Q4 2026 Earnings Call Transcript - The Motley Fool
Kestra Medical Technologies Q4 2026 Earnings Call Transcript - MarketBeat
Kestra Medical Technologies (KMTS) Reports Strong Q4 Fiscal 2026 Earnings - GuruFocus
Kestra FY27 outlook set at $137M as Q4 revenue jumps 66% - scanx.trade
Kestra Medical secures $75M loan facility with Pharmakon By Investing.com - Investing.com South Africa
Kestra Medical Technologies Q4 Earnings Call Highlights - MarketBeat
Kestra Medical (NASDAQ: KMTS) targets $24B wearable defibrillator market - Stock Titan
KESTRA MEDICAL TECHNOLOGIES, LTD. FY 2026: Revenue $95.1M, Net income $(131.6M) — 10-K Summary - TradingView
Kestra Medical Technologies : Annual Report for Fiscal Year Ending April 30, 2026 (Form 10-K) - marketscreener.com
Kestra Medical Technologies, Ltd. (KMTS) Reports Q4 Loss, Tops Revenue Estimates - Yahoo Finance
Kestra Medical Secures Up to $200 Million in Financing From Pharmakon Advisors - marketscreener.com
Kestra Medical Technologies Ltd reports results for the quarter ended April 30Earnings Summary - TradingView
Kemetics (KMTS) Forecasts Significant Revenue Growth for FY27 - GuruFocus
KMTS: Rapidly scaling cardiac care platform addresses a $10B market with proven outcomes and expanding margins - TradingView
Kestra Medical tops Q4 revenue estimates, but posts wider loss than expected - Investing.com
Kestra Medical tops Q4 revenue estimates, but posts wider loss than expected By Investing.com - Investing.com India
Kestra Medical Technologies Secures Up to $200 Million of Non-Dilutive Financing - The Manila Times
Kestra Medical Technologies Secures Up to $200 Million Five-Year Term Loan From BioPharma Credit Funds - TradingView
Kestra Medical Technologies Ltd (KMTS) 財務データ
収益
当期純利益
現金流量
EPS
0.63%
0.82%
大文字化:
|
ボリューム (24 時間):